Literature DB >> 9620561

Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line.

A Krüger1, O H Sanchez-Sweatman, D C Martin, J E Fata, A T Ho, F W Orr, U Rüther, R Khokha.   

Abstract

Within the tumor-stromal microenvironment a disrupted balance between matrix metalloproteinases (MMPs) and their inhibitors compromises the integrity of the extracellular matrix and promotes malignancy. Tissue inhibitors of metalloproteinases (TIMPs) have been linked to tumor suppression in studies of genetically altered tissue culture cells and in analyses of clinical specimens in situ. We generated transgenic mice as a model system to test the relationship between TIMP-1 levels in a host organ and susceptibility to experimentally targeted metastasis. Ectopically overexpressed TIMP-1 in the brain resulted in a tissue microenvironment with elevated protein levels of this natural MMP inhibitor. Metastatic challenge provided by lacZ-tagged fibrosarcoma cells permitted high-resolution analysis of metastatic load and pattern. We found that elevated host TIMP-1 imposed resistance to experimental metastasis of fibrosarcoma: In TIMP-1 overexpressing mice, brain metastases were significantly reduced by 75% compared to wild-type littermates. Our findings demonstrate that ectopic TIMP-1 expression efficiently exerts a suppressive effect on metastasizing tumor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620561     DOI: 10.1038/sj.onc.1201774

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

Review 2.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 3.  Pathobiology of brain metastases.

Authors:  N Nathoo; A Chahlavi; G H Barnett; S A Toms
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

4.  Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).

Authors:  K J Leco; P Waterhouse; O H Sanchez; K L Gowing; A R Poole; A Wakeham; T W Mak; R Khokha
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 6.  Preclinical approaches to study the biology and treatment of brain metastases.

Authors:  William Cruz-Muñoz; Robert S Kerbel
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

7.  Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1.

Authors:  Enling Liu; Zheng Liu; Yuxiu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

8.  Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.

Authors:  Brunilde Gril; Diane Palmieri; Yongzhen Qian; Talha Anwar; David J Liewehr; Seth M Steinberg; Zoraida Andreu; Daniel Masana; Paloma Fernández; Patricia S Steeg; Fernando Vidal-Vanaclocha
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

Review 9.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

10.  Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation.

Authors:  Yuji Kurihara; Masashi Hatori; Yuriko Ando; Daisuke Ito; Takahiko Toyoshima; Makoto Tanaka; Satoru Shintani
Journal:  Clin Exp Metastasis       Date:  2009-02-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.